magnoflorine has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, G; Liu, M; Qin, Y; Sun, J; Tang, H; Wang, W; Zeng, Y; Zhang, J; Zhao, X; Zhong, L | 1 |
1 other study(ies) available for magnoflorine and Alzheimer Disease
| Article | Year |
|---|---|
Magnoflorine improves cognitive deficits and pathology of Alzheimer's disease via inhibiting of JNK signaling pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aporphines; Cognition; MAP Kinase Signaling System; Mice; Reactive Oxygen Species | 2023 |